Oseltamivir Pharmacokinetics, Dosing, and Resistance Among Children Aged <2 Years With Influenza

Background. Children <2 years of age are at high risk of influenza-related mortality and morbidity. However, the appropriate dose of oseltamivir for children <2 years of age is unknown. Methods. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group evalu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kimberlin, David W., Acosta, Edward P., Prichard, Mark N., Sánchez, Pablo J., Ampofo, Krow, Lang, David, Ashouri, Negar, Vanchiere, John A., Abzug, Mark J., Abughali, Nazha, Caserta, Mary T., Englund, Janet A., Sood, Sunil K., Spigarelli, Michael G., Bradley, John S., Lew, Judy, Michaels, Marian G., Wan, Wen, Cloud, Gretchen, Jester, Penelope, Lakeman, Fred D., Whitley, Richard J., Giles, Dusty, Cotton, Bari, Judy, Sharon, Cowie, Margaret, Francis, Jeanne, Evans, Candice, O'Donnell, Nan, Shiraishi, Ofelia Vargas, Latiolais, Lisa, Aymami, Valeri, Dole, Ken, Gaultier, Julie, Lofthus, Gerry, Kinnunen, Diane, Lacombe, Kirsten, Stellato, Nancy, Denlinger, Julie, Hingtgen, Sara, Mason, Christina, Jeffrey, Noreen
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2013
Teme:
Major Articles and Brief Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3563309/
https://ncbi.nlm.nih.gov/pubmed/23230059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis765
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki